Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the safety and drug levels of BMS-986256 in participants with cutaneous lupus erythematosus.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bristol-Myers Squibb
NCT02927457 · Lupus Erythematosus, Cutaneous
NCT02656082 · Lupus Erythematosus, Discoid, Lupus Erythematosus, Cutaneous, and more
NCT00420121 · Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Systemic
NCT02034344 · Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Systemic, and more
NCT01702740 · Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Systemic
Local Institution - 0001
Berlin
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions